Susanna Eketjall

BioPharmaceuticals R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.

MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 03, 2024

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease.

Journal: Cardiovascular research

Published: June 19, 2022

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations.

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations.

Journal: ACR open rheumatology

Published: July 10, 2021

Development of a highly sensitive liquid chromatography-mass spectrometry method to quantify plasma leukotriene E4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man.

Development of a highly sensitive liquid chromatography-mass spectrometry method to quantify plasma leukotriene E4 and demonstrate pharmacological suppression of endogenous 5-LO pathway activity in man.

Journal: Prostaglandins & other lipid mediators

Published: December 19, 2019

Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State.

Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State.

Journal: The Journal of rheumatology

Published: August 23, 2019

Highly sensitive and specific LC-MS/MS method to determine endogenous leukotriene B4 levels in human plasma.

Highly sensitive and specific LC-MS/MS method to determine endogenous leukotriene B4 levels in human plasma.

Journal: Bioanalysis

Published: June 29, 2019

Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.

Microparticles in the blood of patients with SLE: Size, content of mitochondria and role in circulating immune complexes.

Journal: Journal of autoimmunity

Published: March 06, 2019

Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.

Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus.

Journal: Journal of proteome research

Published: February 12, 2019

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.

Journal: Arthritis research & therapy

Published: January 22, 2019

Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity.

Toward β-Secretase-1 Inhibitors with Improved Isoform Selectivity.

Journal: Journal of medicinal chemistry

Published: April 05, 2018

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.

Journal: Lupus science & medicine

Published: January 14, 2018

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.

Journal: Lupus science & medicine

Published: December 18, 2017

Showing 1-12 of 26

Last Updated: 09/26/2026